Device Trial Radar · NCT05224011
Non-invasive Continuous Blood Pressure Monitoring
Last checked: Nov 20, 2026Latest source record: Mar 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8
Actual
Start
Jun 22, 2022
Primary completion
Sep 22, 2022
Study completion Sep 22, 2022
Sponsor
- Lead sponsor
- PyrAmes Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Calgary
- First posted
- Feb 4, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, up to 12 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The Boppli device was designed to provide continuous non-invasive blood pressure (cNIBP) monitoring for infants, including neonates, in intensive care settings by detecting systolic, diastolic, and mean arterial blood pressure values comparable to that of an invasive arterial line (IAL) within published accuracy criteria. The device consists of an array of capacitive sensors contained in a soft, flexible, biocompatible band. It applies proprietary algorithms to capacitance detections to generate accurate systolic, diastolic, and mean arterial blood pressure and waveform data, then communicates the data to an external device via Bluetooth Low Energy for storage and display. It may be applied to the patient's arm or foot on either side of the body, which is advantageous for infants whose bodies provide limited surface area for medical devices or equipment. It does not require high skin pressure when correctly placed. The device is intended for single use of up to 72 hours and is discarded following use.
Conditions
- Blood Pressure
Interventions
Boppli Infant Blood Pressure MonitorDevice
The intervention is a medical device for the non-invasive measurement of blood pressure in infants
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the accuracy and precision of the Boppli System in continuous blood pressure monitoringTime frame: 6 - 72 Hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Foothills Medical Center Neonatal Intensive Care Unit, NICU 51
Calgary, Alberta, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.